![]() Anecdotal use of topical steroid oral prophylaxis has been reported in patients with breast cancer. Topical steroids might reduce stomatitis incidence and severity, and the need for dose reductions and interruptions of everolimus. Stomatitis is a class effect associated with the inhibition of mTOR and is associated with everolimus therapy for breast cancer. ![]() 13 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.12 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.11 Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |